Differential time course of glycogen synthase kinase-3 inhibition in experimental autoimmune encephalomyelitis

Differential time course of glycogen synthase kinase-3 inhibition in experimental autoimmune encephalomyelitis

Introduction: GSK-3 is an immune regulator that plays a role in the modulation of cytokine-producing effector T cells associated with inflammation and demyelination of the CNS in EAE. Objective: This study aimed to evaluate the treatment paradigm of a single dose of GSK-3 inhibitor administration at...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Al-Zaidi, Ahmed Salam, Mohtarrudin, Norhafizah, Hassan, Masriana
Formato:	Artigo
Idioma:	English
Publicado em:	Malaysian Society of Pathologists 2021
Acesso em linha:	http://psasir.upm.edu.my/id/eprint/96733/1/ABSTRACT.pdf

Registros relacionados

Glycogen synthase kinase 3 inhibition controls Mycobacterium tuberculosis infection
por: Sandra Peña-Díaz, et al.
Publicado em: (2024-08-01)

Evaluation of the effective time for GSK-3 inhibition in experimental autoimmune encephalomyelitis mouse model by tideglusib (NP-12) in preventing neuroinflammation
por: Al-Zaidi, Ahmed Salam
Publicado em: (2018)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Michael Basler, et al.
Publicado em: (2014-01-01)

The antimalarial effect of curcumin is mediated by the inhibition of glycogen synthase kinase-3β
por: Ali, Amatul Hamizah, et al.
Publicado em: (2017)

Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3β
por: Yingui Li, et al.
Publicado em: (2020-01-01)

Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease
por: Nahed S. Alharthi, et al.
Publicado em: (2022-01-01)

Glycogen synthase kinase 3 activity enhances liver inflammation in MASH
por: Mireille Khoury, et al.
Publicado em: (2024-06-01)

Medicinal plants with antimalarial activities mediated via glycogen synthase kinase-3 beta (GSK3β) inhibition
por: Hassan, Wan Rozianoor Mohd, et al.
Publicado em: (2022)

Odontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides
por: Vidhyashree Rajasekar, et al.
Publicado em: (2025-02-01)

Extremely tight binding of a ruthenium complex to glycogen synthase kinase 3.
por: Atilla-Gokcumen, G, et al.
Publicado em: (2008)

Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
por: Chen, Chia-Ling, et al.
Publicado em: (2022)

Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
por: Wolfensohn, S, et al.
Publicado em: (2013)

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome
por: McCamphill, Patrick K, et al.
Publicado em: (2021)

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome
por: McCamphill, Patrick K., et al.
Publicado em: (2022)

Naringenin may prevent morphine-induced tolerance via inhibiting glycogen synthase kinase-3beta activity in mice
por: Samira Shirooie, et al.
Publicado em: (2024-03-01)

Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes.
por: Brownlees, J, et al.
Publicado em: (1997)

Glycogen synthase kinase 3 (GSK-3) and its inhibitors : drug discovery and development /
por: Martinez, Ana, 1961-, et al.
Publicado em: (2006)

Effect of Preconditioning with Desflurane on Phosphorylated Glycogen Synthase Kinase 3β Contents in an Experiment
por: V. V. Likhvantsev, et al.
Publicado em: (2017-01-01)

Brief Review of the Role of Glycogen Synthase Kinase-3β in Amyotrophic Lateral Sclerosis
por: Seong-Ho Koh, et al.
Publicado em: (2011-01-01)

Anti-malarial activities of two actinomycete isolates from sabah soil involved inhibition of glycogen synthase kinase 3ß
por: Dhiana Efani Dahari, et al.
Publicado em: (2016)

The Effect of Xenon on the Activity of Glycogen Synthase Kinase-Зβ in the Perifocal Zone of Ischemic Cerebral Infarction (Experimental Study)
por: A. V. Ershov, et al.
Publicado em: (2023-04-01)

R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
por: Katja Schmitz, et al.
Publicado em: (2014-09-01)

Yeast Glycogen Synthase Kinase-3 Pathway Inhibitors from an Organic Extract of Streptomyces sp.
por: Cheenpracha, Sarot, et al.
Publicado em: (2009)

Effect of Xenon on the Phosphorylation of Glycogen Synthase Kinase 3β and Antioxidant Enzymes in Rat Brain
por: A. N. Kuzovlev, et al.
Publicado em: (2021-01-01)

On the role of glycogen synthase kinases in the molecular mechanisms of stress conditions and prospects for the use of lithium ascorbate
por: I. Yu. Torshin, et al.
Publicado em: (2022-10-01)

Anti-malarial and anti-inflammatory effects of Gynura procumbens are mediated by kaempferol via inhibition of glycogen synthase kinase-3ß (GSK3ß)
por: Sok, Kuan Wong, et al.
Publicado em: (2015)

Experimental Autoimmune Encephalomyelitis Development Is Aggravated by Candida albicans Infection
por: Thais F. C. Fraga-Silva, et al.
Publicado em: (2015-01-01)

Preventive Treatment with Methylprednisolone Paradoxically Exacerbates Experimental Autoimmune Encephalomyelitis
por: Simone Wüst, et al.
Publicado em: (2012-01-01)

Sex Effect on Cardiac Damage in Mice With Experimental Autoimmune Encephalomyelitis
por: Ruixia Wu, et al.
Publicado em: (2021-02-01)

Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis
por: Hongryeol Park, et al.
Publicado em: (2024-07-01)

A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
por: Evaristus C. Mbanefo, et al.
Publicado em: (2024-06-01)

Glycogen Synthase Kinase 3β inhibits BMSCs Chondrogenesis in Inflammation via the Cross-Reaction between NF-κB and β-Catenin in the Nucleus
por: Zhenggang Wang, et al.
Publicado em: (2022-01-01)

Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells
por: A. Markovska, et al.
Publicado em: (2024-09-01)

Oxidative stress regulates glycogen synthase kinase-3 in lymphocytes of diabetes mellitus patients complicated with cerebral infarction
por: Wang Man, et al.
Publicado em: (2024-11-01)

Glycogen Synthase Kinase-3 Regulates Production of Amyloid-β Peptides and Tau Phosphorylation in Diabetic Rat Brain
por: Zhong-Sen Qu, et al.
Publicado em: (2014-01-01)

Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach
por: Shabir Ahmad Ganai, et al.
Publicado em: (2025-02-01)

The Mechanisms of Pharmacological Preconditioning of the Brain and the Comparative Efficacy of the Drugs — Direct- and Indirect-Acting Glycogen Synthase Kinase-3β Inhibitors: Experimental Study
por: V. V. Likhvantsev, et al.
Publicado em: (2012-12-01)

Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
por: Fridkis-Hareli, M, et al.
Publicado em: (2002)

Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.
por: Mengozzi, M, et al.
Publicado em: (2008)

A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.
por: Jagodic, M, et al.
Publicado em: (2009)